Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)
Vietnam
· Delayed Price · Currency is VND 53,300
-600 (-1.11%)
At close: Mar 5, 2026
HOSE:DBD Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,865,232 | 1,727,548 | 1,651,770 | 1,554,821 | 1,558,504 | Upgrade
|
| Revenue Growth (YoY) | 7.97% | 4.59% | 6.24% | -0.24% | 23.99% | Upgrade
|
| Cost of Revenue | 983,372 | 894,975 | 853,250 | 787,170 | 935,939 | Upgrade
|
| Gross Profit | 881,861 | 832,573 | 798,520 | 767,652 | 622,566 | Upgrade
|
| Selling, General & Admin | 557,161 | 526,981 | 501,538 | 494,312 | 405,437 | Upgrade
|
| Operating Expenses | 557,161 | 526,981 | 501,538 | 494,312 | 405,437 | Upgrade
|
| Operating Income | 324,700 | 305,592 | 296,982 | 273,339 | 217,129 | Upgrade
|
| Interest Expense | -3,847 | -4,058 | -6,998 | -1,916 | -1,325 | Upgrade
|
| Interest & Investment Income | 20,036 | 11,605 | 11,635 | 8,733 | 5,137 | Upgrade
|
| Earnings From Equity Investments | 12,280 | 27,063 | 28,704 | 24,786 | 16,083 | Upgrade
|
| Currency Exchange Gain (Loss) | 2,644 | -947.49 | -482.96 | 354.16 | 733.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -11,308 | -12,119 | -9,753 | -6,739 | -5,310 | Upgrade
|
| EBT Excluding Unusual Items | 344,506 | 327,136 | 320,086 | 298,558 | 232,448 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -2,000 | - | - | - | Upgrade
|
| Pretax Income | 344,506 | 325,136 | 320,086 | 298,558 | 232,448 | Upgrade
|
| Income Tax Expense | 53,758 | 49,954 | 51,031 | 55,003 | 43,324 | Upgrade
|
| Net Income | 290,748 | 275,182 | 269,055 | 243,555 | 189,124 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 38,525 | 37,668 | 34,098 | 26,477 | Upgrade
|
| Net Income to Common | 290,748 | 236,656 | 231,387 | 209,457 | 162,646 | Upgrade
|
| Net Income Growth | 5.66% | 2.28% | 10.47% | 28.78% | 19.80% | Upgrade
|
| Shares Outstanding (Basic) | 94 | 94 | 94 | 94 | 94 | Upgrade
|
| Shares Outstanding (Diluted) | 94 | 94 | 94 | 94 | 94 | Upgrade
|
| Shares Change (YoY) | 1.00% | - | -0.00% | - | -0.07% | Upgrade
|
| EPS (Basic) | 3077.05 | 2529.63 | 2473.31 | 2238.88 | 1738.52 | Upgrade
|
| EPS (Diluted) | 3077.05 | 2529.63 | 2473.00 | 2238.88 | 1738.52 | Upgrade
|
| EPS Growth | 21.64% | 2.29% | 10.46% | 28.78% | 17.16% | Upgrade
|
| Free Cash Flow | 216,289 | 115,985 | 148,663 | 82,184 | 62,932 | Upgrade
|
| Free Cash Flow Per Share | 2289.03 | 1239.77 | 1589.06 | 878.47 | 672.68 | Upgrade
|
| Dividend Per Share | - | 2000.000 | - | 1600.000 | - | Upgrade
|
| Gross Margin | 47.28% | 48.19% | 48.34% | 49.37% | 39.95% | Upgrade
|
| Operating Margin | 17.41% | 17.69% | 17.98% | 17.58% | 13.93% | Upgrade
|
| Profit Margin | 15.59% | 13.70% | 14.01% | 13.47% | 10.44% | Upgrade
|
| Free Cash Flow Margin | 11.60% | 6.71% | 9.00% | 5.29% | 4.04% | Upgrade
|
| EBITDA | 374,264 | 352,272 | 342,951 | 315,005 | 255,818 | Upgrade
|
| EBITDA Margin | 20.06% | 20.39% | 20.76% | 20.26% | 16.41% | Upgrade
|
| D&A For EBITDA | 49,565 | 46,679 | 45,970 | 41,665 | 38,689 | Upgrade
|
| EBIT | 324,700 | 305,592 | 296,982 | 273,339 | 217,129 | Upgrade
|
| EBIT Margin | 17.41% | 17.69% | 17.98% | 17.58% | 13.93% | Upgrade
|
| Effective Tax Rate | 15.60% | 15.36% | 15.94% | 18.42% | 18.64% | Upgrade
|
| Revenue as Reported | 1,865,232 | 1,727,548 | 1,651,770 | 1,554,821 | 1,558,504 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.